Synlab, officially known as Synlab International GmbH, is a leading provider of laboratory services headquartered in Germany. Established in 2015, the company has rapidly expanded its operations across Europe, with a strong presence in countries such as France, Italy, and Spain. Specialising in medical diagnostics, environmental testing, and food safety, Synlab offers a comprehensive range of services that are distinguished by their commitment to quality and innovation. With a focus on advanced laboratory technology and a robust network of facilities, Synlab has positioned itself as a trusted partner in the healthcare and environmental sectors. The company has achieved significant milestones, including numerous accreditations and partnerships that enhance its market standing. By prioritising accuracy and efficiency, Synlab continues to set benchmarks in the laboratory services industry, making it a preferred choice for clients seeking reliable and timely results.
How does Synlab's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Synlab's score of 55 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, SYNLAB reported total carbon emissions of approximately 436.3 million kg CO2e, comprising 18.5 million kg CO2e from Scope 1, 12.2 million kg CO2e from Scope 2 (market-based), and 405.6 million kg CO2e from Scope 3 emissions. The previous year, 2023, saw total emissions of about 442.2 million kg CO2e, with Scope 1 emissions at 19.9 million kg CO2e, Scope 2 (market-based) at 11.5 million kg CO2e, and Scope 3 at 410.7 million kg CO2e. SYNLAB has committed to becoming carbon neutral by 2025, focusing on reducing operational emissions (Scope 1 and 2) and offsetting any remaining unavoidable emissions. This commitment is part of their broader climate strategy, which includes annual reductions in greenhouse gas emissions. The company is actively working towards these targets, with specific initiatives aimed at decreasing emissions intensity. The emissions data is sourced directly from SYNLAB AG, with no cascaded data from parent or related organizations. The company is classified under the healthcare sector and is based in Germany.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 22,155,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 16,535,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000,000 | 000,000,000 |
Synlab's Scope 3 emissions, which decreased by 1% last year and decreased by approximately 1% since 2023, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 87% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Synlab has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Synlab's sustainability data and climate commitments
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.